http://newsroom.lilly.com/index.cfm?sh_auth=587754909.0.0.67cf94123e271800cfb2e764a10f50b3en-usShareholder.com RSS Feedhttp://newsroom.lilly.com/releasedetail.cfm?ReleaseID=425121Wed, 18 Nov 2009 18:11:00 GMThttp://newsroom.lilly.com/releasedetail.cfm?ReleaseID=425121New Updates to AHA/ACC/SCAI Clinical Guidelines Recommend Treatment with Effient(R) for Patients with Acute Coronary Syndromes Managed with PCIhttp://newsroom.lilly.com/releasedetail.cfm?ReleaseID=424349Mon, 16 Nov 2009 13:00:00 GMThttp://newsroom.lilly.com/releasedetail.cfm?ReleaseID=424349Lilly Surpasses United Way 2009 Campaign Goalhttp://newsroom.lilly.com/releasedetail.cfm?ReleaseID=424274Sun, 15 Nov 2009 21:15:44 GMThttp://newsroom.lilly.com/releasedetail.cfm?ReleaseID=424274Efient(R) Exhibited Greater Antiplatelet Activity than High Dose Clopidogrel in Type 2 Diabetes Mellitus Patients with Coronary Artery Diseasehttp://newsroom.lilly.com/releasedetail.cfm?ReleaseID=424271Sun, 15 Nov 2009 20:00:00 GMThttp://newsroom.lilly.com/releasedetail.cfm?ReleaseID=424271Effient(R) Exhibited Greater Antiplatelet Activity than High Dose Clopidogrel in Type 2 Diabetes Mellitus Patients with Coronary Artery Diseasehttp://newsroom.lilly.com/releasedetail.cfm?ReleaseID=424135Fri, 13 Nov 2009 14:00:00 GMThttp://newsroom.lilly.com/releasedetail.cfm?ReleaseID=424135Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his Successorhttp://newsroom.lilly.com/releasedetail.cfm?ReleaseID=423537Wed, 11 Nov 2009 14:00:00 GMThttp://newsroom.lilly.com/releasedetail.cfm?ReleaseID=423537Deadline Extended to December 16 to Submit Nominations for Depression Awards Programhttp://newsroom.lilly.com/releasedetail.cfm?ReleaseID=422936Mon, 09 Nov 2009 19:01:00 GMThttp://newsroom.lilly.com/releasedetail.cfm?ReleaseID=422936Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Dayhttp://newsroom.lilly.com/releasedetail.cfm?ReleaseID=421914Wed, 04 Nov 2009 19:27:00 GMThttp://newsroom.lilly.com/releasedetail.cfm?ReleaseID=421914Oncology On Canvas(SM) Launches 2010 Art Competition for Individuals Touched by Cancerhttp://newsroom.lilly.com/releasedetail.cfm?ReleaseID=421030Mon, 02 Nov 2009 20:30:00 GMThttp://newsroom.lilly.com/releasedetail.cfm?ReleaseID=421030Amylin Pharmaceuticals and Eli Lilly and Company Statement on FDA's BYETTA(R) (Exenatide) Injection Updatehttp://newsroom.lilly.com/releasedetail.cfm?ReleaseID=420602Sat, 31 Oct 2009 00:16:00 GMThttp://newsroom.lilly.com/releasedetail.cfm?ReleaseID=420602BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes